With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Need to harmonize traditional and modern medicine to combat alarming health problems
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Subscribe To Our Newsletter & Stay Updated
